Oral, Head, Neck & Thyroid Cancers Information

Return to Previous Page

Get Help for Speech and Swallowing Difficulties after Head and Neck Cancer

by Mary J. Bacon, MA, CCC-SLP, BCS-S

A diagnosis of head and neck can­cer often raises concerns about speech clarity, voice quality, and swallowing ability. The degree to which a person’s speech and swallowing func­tions are affected varies depending on the type, size, and location of the tumor and the method used to treat it. Some people glide through treatment with little difficulty, while others experience impairment that is more extensive.

Read More


Managing Speech and Swallowing Complications Resulting from Head and Neck Cancer

by Jan S. Lewin, PhD

Head and neck cancer often results in significant functional changes in speech, voice, and swallowing. These problems can occur as a result of the disease or of the treatment. It is important to have a thorough and real­istic understanding of the functional effects of treatment because the restora­tion of communication and the ability to swallow may be critical to your treatment decision.

Read More


Swallowing Exercises Shown to Preserve Function in People with Head and Neck Cancer Receiving Radiation

A study from UCLA’s Jonsson Com­prehensive Cancer Center has found that people with head and neck cancer receiv­ing radiation as part of their treatment were less likely to experience unwanted side effects such as worsening of diet, need for a feeding tube, or narrowing of the throat passage if they complied with a set of prescribed swallowing exercises during therapy.

Read More


FDA Approves Nexavar to Treat Type of Thyroid Cancer

The U.S. Food and Drug Administration has expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer. The drug’s new use is intended for patients with locally recurrent or metastatic, progressive differentiated thyroid cancer that no longer responds to radioactive iodine treatment.

Read More


FDA Approves Cometriq to Treat Rare Type of Thyroid Cancer

The FDA completed review of Cometriq’s application in six months under the agency’s priority review program. This program provides for an expedited six-month review for drugs that may offer major advances in treatment or that provide a treatment when no adequate therapy exists. Cometriq also received orphan-product designation by the FDA because it is intended to treat a rare disease or condition.

Read More


Radiotherapy for Head and Neck Cancer

Most types of head and neck cancer start in the cells lin­ing the open cavities of the head and neck, such as the sinuses, na­sal cavity, mouth, or throat. Other kinds of head and neck cancer can occur in the salivary glands. These glands pro­duce the fluid, called “saliva” or spit, that keeps your mouth and throat moist.

Read More


Understanding Radiotherapy for Head and Neck Cancer

According to the National Cancer Institute, head and neck cancer accounts for nearly 3 to 5 percent of all cancer in the United States. These types of cancer are more common in men and in people older than age 50. Around 47,560 men and women in this country develop head and neck cancer every year. Tobacco and alcohol use are common risk factors for this cancer.

Read More


Most People Can Speak and Swallow After Combination Treatment for Head and Neck Cancer

Most people do not have ongoing speaking or swallowing difficulties following combined chemotherapy and radiation treatment for advanced head or neck cancer, but several factors may be associated with worse outcomes in these functions.

Read More


Page 1 of 2  1 2 > 


eUpdate Sign up

Receive e-mails with links to the latest content on the Coping with Cancer website.

See past issues of eUpdate.

Follow us on Twitter

          Twitter icon

Like us on Facebook

          FaceBook icon

Subscribe to
Coping with Cancer magazine